Okayama University Research: Prosthetics for Retinal Stimulation

OKAYAMA, Japan, July 29, 2019 /PRNewswire/ — In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University report a thin photoelectric film which can stimulate degenerated retinal tissues of the eye.

Using electric signals to stimulate tissues is the basis of several medical devices such as pacemakers for the heart or neurostimulators used for patients suffering from epileptic fits. A research team led by Dr. MATSUO toshihiko at Okayama University has developed OURePTM, a photoelectric dye-coupled thin film device that generates electric potential changes when exposed to light. In their latest study, the research team reveals the ability of this device in stimulating degenerated retinal tissues.

OURePTM is generated by placing polyethylene, a polymer, between two aluminum plates. When the polymer is melted, and a high pressure applied subsequently, a fine polyethylene film is created. The film then undergoes a chemical reaction wherein it is coupled to a photoelectric dye.

The researchers first placed the photoelectric dye-coupled film on the electric potential-measuring device and exposed it to flashing light. As expected, waves of electric signals were observed on the film surface when light hit the film. To then test the ability of this film in stimulating nervous tissue, retinal tissues of rats with retinal dystrophy, a retinal degenerative disorder, were procured. When the retinal tissues of healthy rats were brought to close contact with a multielectrode array, a device used to measure electrical signals from biological tissues, and exposed to light, corresponding waves of electric signals were observed. However, no such signals were observed with the dystrophic retinal tissue. The photoelectric dye-coupled film was then placed on top of the dystrophic tissues which resulted in the induction of electric signals in response to bouts of light. A control film, without the photoelectric dye did not induce electric signals in these tissues.

To measure these electric signals more precisely, a nylon mesh was used to keep the dystrophic tissues and the multielectrode array detector in closer contact. This proximity revealed background electric impulses of weak amplitude with the dystrophic retinal tissues alone. In the background of weak amplitude of these signals, light induced remarkable action potential spikes in the dystrophic retinal tissues, in the presence of the photoelectric dye-coupled film. The photoelectric dye-coupled film was thus instrumental in boosting electrical impulses within the degenerated retina.

“The current study provides direct evidence for the ability of the photoelectric dye-coupled polyethylene film to elicit electroretinogram-like response and action potential spikes in degenerative retina,” conclude the researchers. Retinitis pigmentosa, is one such condition, wherein photoreceptors of the eye slowly die, leading to blindness. This study revealed the prosthetic value of OURePTM in potentially replacing the lost photosensitivity of these cells. Implanting the device and testing visual enhancement in animals in their preceding studies have already given further insights.

Background

Photoelectric dye: A photoelectric dye is an organic molecule that can absorb light and emit electric signals. The dye thus converts light energy into electrical energy. When these dye molecules are coupled to the surface of biological safe polymers such as polyethylene, they can be implanted onto tissue surfaces and used for their electrical impulse-generating properties to stimulate the surrounding tissues.

Reference

Toshihiko Matsuo, Mikako Sakurai, Keiko Terada, Tetsuya Uchida, Koichiro Yamashita, Tenu Tanaka, Kenichi Takarabe. Photoelectric Dye-Coupled Polyethylene Film: Photoresponsive Properties Evaluated by Kelvin Probe and In Vitro Biological Response Detected in Dystrophic Retinal Tissue of Rats. Advanced Biomedical Engineering, May 2019.

DOI : https://doi.org/10.14326/abe.8.137

https://www.jstage.jst.go.jp/article/abe/8/0/8_8_137/_article/-char/en

Correspondence to

Associate Professor MATSUO Toshihiko, M.D., Ph.D.
Ophthalmology, Okayama University Medical School and
Graduate School of Interdisciplinary Science and Engineering
in Health Systems,
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan

Okayama University Medical Research Updates OU-MRU

The whole volume : OU-MRU (1- 69)

Vol.1:Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testing

Vol.69:Early gastric cancer endoscopic diagnosis system using artificial intelligence

About Okayama University

Okayama University is one of the largest comprehensive universities in Japan with roots going back to the Medical Training Place sponsored by the Lord of Okayama and established in 1870. Now with 1,300 faculty and 13,000 students, the University offers courses in specialties ranging from medicine and pharmacy to humanities and physical sciences. Okayama University is located in the heart of Japan approximately 3 hours west of Tokyo by Shinkansen.

Website: http://www.okayama-u.ac.jp/index_e.html

Further information
Okayama University
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations Division
E-mail: www-adm@adm.okayama-u.ac.jp 
Website: http://www.okayama-u.ac.jp/index_e.html 
Okayama Univ. e-Bulletin: http://www.okayama-u.ac.jp/user/kouhou/ebulletin/
About Okayama University (YouTube): https://www.youtube.com/watch?v=iDL1coqPRYI

View original content:http://www.prnewswire.com/news-releases/okayama-university-research-prosthetics-for-retinal-stimulation-300892102.html

SOURCE Okayama University

Staff

Recent Posts

Interim Report January – June 2024

GOTHENBURG, SWEDEN / ACCESSWIRE / July 12, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Second quarter 2024…

40 mins ago

Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain…

10 hours ago

Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain…

10 hours ago

Westlake Vinnolit Customers Appreciate Joint Efforts on Decarbonization

Westlake Vinnolit won the PVC category of the 2024 ‘Polymer Producer Awards’ by the Polymers…

10 hours ago

Neogen Announces Fourth-Quarter Earnings Release Date

LANSING, Mich., July 11, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its fourth-quarter…

10 hours ago

CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE

BEIJING, July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the…

10 hours ago